Posts

Welcome to the Fritsma Factor, please join our hemostasis discussions.

This case study is the first instance I've [Geo] seen describing the development of an anti-...
Nov 22, 2021 11:16am
A timely question from Frank Cragg, MD, Nova Scotia Health. "Hi, I have the IL 750 ready to...
Nov 18, 2021 5:44pm
From Hillary Thurman: Here is some additional information, in response to Bob Gosselin's 11-6-21...
Nov 8, 2021 11:36am
Hillary Thurman is looking for some insight, She writes, "We have recently standardized hemostasis...
Nov 6, 2021 6:29pm
Nov 22, 2021 11:16am
This case study is the first instance I've [Geo] seen describing the development of an anti-emicizumab antibody that appears to suppress hemophilia A therapy: /sites/default/files/anti-emicizumab_kaneda_jth_2021.pdf
0 Comments
Nov 18, 2021 5:44pm
A timely question from Frank Cragg, MD, Nova Scotia Health. "Hi, I have the IL 750 ready to implement but am getting conflicting information on how much hemolysis to allow. Please help. Regards, Frank Cragg MD, FRCPC (C).
0 Comments
Nov 8, 2021 11:36am
From Hillary Thurman: Here is some additional information, in response to Bob Gosselin's 11-6-21 response:
0 Comments
Nov 6, 2021 6:29pm
Hillary Thurman is looking for some insight, She writes, "We have recently standardized hemostasis instruments across our system. The rest of the system has been using a combined geometric mean for their PT reagent (same lot, same instruments), but my site has never been involved in this. In addition, they do not change the geomean between reagent lots unless the new lot geomean is more than +/- 0.3 from the current lot."
1 Comment